Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro
S Grobbelaar, AE Mercier… - Clinical and …, 2024 - Wiley Online Library
The generation of tissue from stem cells is an alluring concept as it holds a number of
potential applications in clinical therapeutics and regenerative medicine. Mesenchymal …
potential applications in clinical therapeutics and regenerative medicine. Mesenchymal …
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support …
G Falconi, E Galossi, E Fabiani, M Pieraccioli… - Scientific Reports, 2022 - nature.com
Bone marrow mesenchymal stem cells (BM-MSCs) exhibit multiple abnormalities in
myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML), including reduced …
myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML), including reduced …
[PDF][PDF] Giulia Falconi, Elisa Galossi, Emiliano Fabiani, Marco Pieraccioli 3, Serena Travaglini, Hajro Hajrullaj, Raffaella Cerretti, Raffaele Palmieri, Roberto Latagliata 4 …
MT Voso - Scientific Reports, 2022 - academia.edu
Results Phenotype of MSC in myeloid neoplasms. We studied morphologic alterations in
MSC isolated and expanded from the BM-MNC of patients with myeloid neoplasms …
MSC isolated and expanded from the BM-MNC of patients with myeloid neoplasms …